Yue-Lin Zhang Selected Research

Yue-Lin Zhang Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2019
5	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2017
3	Hemorrhage 12/2022 - 09/2017
3	Thrombosis (Thrombus) 01/2021 - 05/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2015 - 12/2014
2	Fibrosis (Cirrhosis) 12/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2017
2	Glioma (Gliomas) 11/2020 - 10/2018
2	Ischemic Stroke 10/2019 - 09/2015
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Hepatitis B 12/2022
1	Portal Hypertension 12/2022
1	Varicose Veins (Varicose Vein) 12/2022
1	End Stage Liver Disease 01/2021
1	Ascites 01/2021
1	Lentivirus Infections 03/2020
1	Nausea 01/2020
1	Vomiting 01/2020
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Cholangiocarcinoma 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019
1	Stroke (Strokes) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2018
1	Hypertrophy 02/2018
1	Reperfusion Injury 09/2015
1	Brain Ischemia (Cerebral Ischemia) 09/2015
1	Edema (Dropsy) 09/2015
1	Spinal Cord Ischemia 09/2015
1	Pain (Aches) 05/2015
1	Hemangioma (Angioma) 01/2015
1	Parkinson Disease (Parkinson's Disease) 12/2014
1	Nervous System Diseases (Neurological Disorders) 12/2014
1	Heart Neoplasms 05/2012
1	Carcinoma (Carcinomatosis) 03/2012
1	Vascular Diseases (Vascular Disease) 01/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2014
3	Neuroprotective AgentsIBA 09/2015 - 12/2014
2	Sirtuin 3IBA 10/2018 - 12/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2023
1	EnbucrilateIBA 12/2022
1	huaierIBA 01/2021
1	U 0126 (UO 126)IBA 11/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2020
1	Temozolomide (Temodar)FDA LinkGeneric 11/2020
1	Caspase 3 (Caspase-3)IBA 11/2020
1	Green Fluorescent ProteinsIBA 03/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	erucylphosphocholineIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	EndostatinsIBA 01/2020
1	Cytosine DeaminaseIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Nogo Receptor 1IBA 10/2019
1	NgR(310) Ecto-Fc proteinIBA 10/2019
1	Epirubicin (Ellence)FDA LinkGeneric 02/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018
1	Exenatide (Byetta)FDA Link 10/2018
1	EnzymesIBA 09/2015
1	AntioxidantsIBA 09/2015
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 09/2015
1	Dynamins (Dynamin)IBA 09/2015
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 09/2015
1	ChitosanIBA 09/2015
1	CollagenIBA 09/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2015
1	Metabotropic Glutamate 5 ReceptorIBA 05/2015
1	3- cyano- N- (1,3- diphenyl- 1H- pyrazol- 5- yl)benzamideIBA 05/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2015
1	Ethiodized Oil (Ethiodol)FDA Link 01/2015
1	bleomycetinIBA 01/2015
1	Matrix Metalloproteinases (MMPs)IBA 12/2014
1	Adenosine Triphosphate (ATP)IBA 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014
1	N-Methylaspartate (NMDA)IBA 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2014
1	Cytochromes c (Cytochrome c)IBA 12/2014
1	2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA 12/2014
1	SuspensionsIBA 03/2012

Therapy/Procedure

6	Therapeutics 01/2020 - 05/2012
3	Microspheres (Microsphere) 01/2021 - 01/2017
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022 - 01/2021
2	Transjugular Intrahepatic Portasystemic Shunt 12/2022 - 01/2021
2	Hepatectomy 01/2020 - 02/2018
2	Pancreaticoduodenectomy 01/2018 - 09/2017
2	Transplantation 09/2015 - 01/2012
1	Drug Therapy (Chemotherapy) 02/2019
1	Palliative Care (Palliative Therapy) 01/2017